Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Endothelial cell dysfunction and cardiac hypertrophy in the STOX1 model of preeclampsia.

Ducat A, Doridot L, Calicchio R, Méhats C, Vilotte JL, Castille J, Barbaux S, Couderc B, Jacques S, Letourneur F, Buffat C, Le Grand F, Laissue P, Miralles F, Vaiman D.

Sci Rep. 2016 Jan 13;6:19196. doi: 10.1038/srep19196.

2.

STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas.

Rigourd V, Chauvet C, Chelbi ST, Rebourcet R, Mondon F, Letourneur F, Mignot TM, Barbaux S, Vaiman D.

PLoS One. 2008;3(12):e3905. doi: 10.1371/journal.pone.0003905. Epub 2008 Dec 11.

3.

Nitroso-redox balance and mitochondrial homeostasis are regulated by STOX1, a pre-eclampsia-associated gene.

Doridot L, Châtre L, Ducat A, Vilotte JL, Lombès A, Méhats C, Barbaux S, Calicchio R, Ricchetti M, Vaiman D.

Antioxid Redox Signal. 2014 Aug 20;21(6):819-34. doi: 10.1089/ars.2013.5661. Epub 2014 Jun 20.

4.

Targeting STOX1 in the therapy of preeclampsia.

Vaiman D, Miralles F.

Expert Opin Ther Targets. 2016 Dec;20(12):1433-1443. Epub 2016 Nov 8. Review.

PMID:
27782763
5.

Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment.

Doridot L, Passet B, Méhats C, Rigourd V, Barbaux S, Ducat A, Mondon F, Vilotte M, Castille J, Breuiller-Fouché M, Daniel N, le Provost F, Bauchet AL, Baudrie V, Hertig A, Buffat C, Simeoni U, Germain G, Vilotte JL, Vaiman D.

Hypertension. 2013 Mar;61(3):662-8. doi: 10.1161/HYPERTENSIONAHA.111.202994. Epub 2013 Jan 28.

PMID:
23357179
6.

STOX1: Key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation.

van Dijk M, Oudejans CB.

J Pregnancy. 2011;2011:521826. doi: 10.1155/2011/521826. Epub 2010 Dec 15. Review.

7.

Meta-Analysis of Placental Transcriptome Data Identifies a Novel Molecular Pathway Related to Preeclampsia.

van Uitert M, Moerland PD, Enquobahrie DA, Laivuori H, van der Post JA, Ris-Stalpers C, Afink GB.

PLoS One. 2015 Jul 14;10(7):e0132468. doi: 10.1371/journal.pone.0132468. eCollection 2015.

8.

Landscape of transcriptional deregulations in the preeclamptic placenta.

Vaiman D, Calicchio R, Miralles F.

PLoS One. 2013 Jun 13;8(6):e65498. doi: 10.1371/journal.pone.0065498. Print 2013.

9.

Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.

Donker RB, Asgeirsdóttir SA, Gerbens F, van Pampus MG, Kallenberg CG, te Meerman GJ, Aarnoudse JG, Molema G.

J Soc Gynecol Investig. 2005 Feb;12(2):98-106.

PMID:
15695104
10.

Preeclamptic plasma induces transcription modifications involving the AP-1 transcriptional regulator JDP2 in endothelial cells.

Calicchio R, Buffat C, Mathieu JR, Ben Salem N, Mehats C, Jacques S, Hertig A, Berkane N, Grevoul-Fresquet J, Simeoni U, Peyssonnaux C, Gavard J, Vaiman D, Miralles F.

Am J Pathol. 2013 Dec;183(6):1993-2006. doi: 10.1016/j.ajpath.2013.08.020. Epub 2013 Oct 10.

PMID:
24120378
11.

Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample.

Kivinen K, Peterson H, Hiltunen L, Laivuori H, Heino S, Tiala I, Knuutila S, Rasi V, Kere J.

Eur J Hum Genet. 2007 Apr;15(4):494-7. Epub 2007 Feb 7.

12.

Re-evaluation of the role of STOX1 transcription factor in placental development and preeclampsia.

Rigourd V, Chelbi S, Chauvet C, Rebourcet R, Barbaux S, Bessières B, Mondon F, Mignot TM, Danan JL, Vaiman D.

J Reprod Immunol. 2009 Nov;82(2):174-81. doi: 10.1016/j.jri.2009.05.001. Epub 2009 Jul 3. Review.

PMID:
19577309
13.

[Endothelial dysfunction: role in the maternal syndrome of preeclampsia and long-term consequences for the cardiovascular system].

Calicchio R, Buffat C, Vaiman D, Miralles F.

Ann Cardiol Angeiol (Paris). 2013 Jun;62(3):215-20. doi: 10.1016/j.ancard.2013.03.002. Epub 2013 Apr 11. Review. French.

PMID:
23721989
14.

Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women.

Tuzcu ZB, Asicioglu E, Sunbul M, Ozben B, Arikan H, Koc M.

Am J Obstet Gynecol. 2015 Oct;213(4):533.e1-7. doi: 10.1016/j.ajog.2015.06.043. Epub 2015 Jun 25.

PMID:
26116870
15.

Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia.

Wang Y, Adair CD, Weeks JW, Lewis DF, Alexander JS.

J Soc Gynecol Investig. 1999 May-Jun;6(3):136-41.

PMID:
10376269
16.

Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: a mechanism by which the placenta communicates with the maternal endothelium.

Shen F, Wei J, Snowise S, DeSousa J, Stone P, Viall C, Chen Q, Chamley L.

Placenta. 2014 Oct;35(10):839-47. doi: 10.1016/j.placenta.2014.07.009. Epub 2014 Jul 24.

PMID:
25096950
17.

Activin and NADPH-oxidase in preeclampsia: insights from in vitro and murine studies.

Lim R, Acharya R, Delpachitra P, Hobson S, Sobey CG, Drummond GR, Wallace EM.

Am J Obstet Gynecol. 2015 Jan;212(1):86.e1-12. doi: 10.1016/j.ajog.2014.07.021. Epub 2014 Jul 18.

PMID:
25046804
18.

Preeclampsia induced by STOX1 overexpression in mice induces intrauterine growth restriction, abnormal ultrasonography and BOLD MRI signatures.

Collinot H, Marchiol C, Lagoutte I, Lager F, Siauve N, Autret G, Balvay D, Renault G, Salomon LJ, Vaiman D.

J Hypertens. 2018 Jun;36(6):1399-1406. doi: 10.1097/HJH.0000000000001695.

PMID:
29465714
19.

Sera from early-onset, severely preeclamptic women directly modulate HLA-E expression in the EA.hy296 endothelial cell line.

Bueno-Sánchez JC, Peña-Alzate S, Peña RB, Agudelo-Jaramillo B, Cadavid-Jaramillo AP, Chaouat G, Maldonado-Estrada JG.

J Reprod Immunol. 2014 Oct;104-105:68-79. doi: 10.1016/j.jri.2014.03.004. Epub 2014 Apr 12.

PMID:
24837231
20.

The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2.

Merchant SJ, Narumiya H, Zhang Y, Guilbert LJ, Davidge ST.

Hypertens Pregnancy. 2004;23(1):47-60.

PMID:
15117600

Supplemental Content

Support Center